H-151, a selective antagonist of STING, has been shown to abate inflammation and improve cardiac function after MI, reduce TNF-α, chemokine (C-X-C motif) ligands (CXCL)10, and IL-1β levels, and restore EF and FS. The gene discussed is STING1; the disease is myocardial infarction.